These stocks offer above-average yields ranging between 2.8% and 5.1%.If you've got $5,000 you can afford to invest in the stock market today, there are some good opportunities that can make the most of that money. Not only can you find some good long-term buys trading at cheap valuations, but there are also some safe dividend stocks that are trading near their 52-week lows.Buying dividend stocks at modest valuations can give you the opportunity to lock in higher-than-normal yields while also potentially se ...

The majority of the Retail - Pharmacies and Drug Stores heavyweights have been southbound due to the ongoing pressure of rising expenses and labor shortages. Consumers have limited money to spend, which is leading to a decline in retail pharmacy products. Added to this, the entire retail pharmacy industry is currently grappling with continued pressure from non-reimbursable pharmacy expenses, which are significantly pulling down mass demand for prescription as well as over-the-counter drugs and vaccinations. ...

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), of the important September 10, 2024 lead plaintiff deadline. SO WHAT: If you purchased CVS securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Sept. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS).Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=100113&from=4CLASS PERIOD: May 3, 20 ...

CVS Health (CVS) stock closed at $57.24 on Monday, quite near to its 52-week low of $52.77. The stock has plunged 27.5% year to date, demonstrating the underlying challenges of the retail pharmacy industry. Investors’ sentiment continues to be bearish in spite of the company delivering second-quarter 2024 earnings surprise and recording margin expansion last month.However, this PBM and pharmacy retail powerhouse has outperformed the broader Retail Pharmacy and Drug Store industry, which plunged 35.1% during ...

SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) --  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024, inclusive (the “Class Period”), have until Tuesday, September 10, 2024 to seek appointment as lead plaintiff of the CVS class action lawsuit. Captioned Nixon v. CVS Health Corporation, No. 24-cv-05303 (S.D.N.Y.), the CVS class action lawsuit charges CVS and certain of CVS’s top current and former execut ...

NEW YORK, Sept. 1, 2024 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the "Class Period"), of the important September 10, 2024 lead plaintiff deadline.So what: If you purchased CVS Securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do ne ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises CVS Health Corporation ("CVS Health" or the "Company") (NYSE: CVS) investors of a class action representing investors that bought securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"). CVS Health investors have until September 10, 2024 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesl ...

NEW YORK, Aug. 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS).Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=98712&from=4CLASS PERIOD: May 3, 202 ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), of the important September 10, 2024 lead plaintiff deadline. SO WHAT: If you purchased CVS Securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...